Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Influenza

Free Subscription Articles published in PLoS Med Retrieve available abstracts of 50 articles: HTML format

Single Articles

September 2021
1. MUTHUKUMAR AV, Morrell W, Bierer BE
   Evaluating the frequency of English language requirements in clinical trial eligibility criteria: A systematic analysis using ClinicalTrials.gov.
   PLoS Med. 2021;18:e1003758.
   PubMed     Abstract available
   
   
   August 2021
2. BRUMMER LE, Katzenschlager S, Gaeddert M, Erdmann C, et al
   Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis.
   PLoS Med. 2021;18:e1003735.
   PubMed     Abstract available
   
   
   
3. KILMARX PH, Glass RI
   Building global health research capacity to address research imperatives following the COVID-19 pandemic.
   PLoS Med. 2021;18:e1003753.
   PubMed     Abstract available
   
   
   July 2021
4. SULIS G, Batomen B, Kotwani A, Pai M, et al
   Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: An interrupted time series analysis.
   PLoS Med. 2021;18:e1003682.
   PubMed     Abstract available
   
   
   
5. IWANAMI S, Ejima K, Kim KS, Noshita K, et al
   Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study.
   PLoS Med. 2021;18:e1003660.
   PubMed     Abstract available
   
   
   
6. KANDULA S, Shaman J
   Investigating associations between COVID-19 mortality and population-level health and socioeconomic indicators in the United States: A modeling study.
   PLoS Med. 2021;18:e1003693.
   PubMed     Abstract available
   
   
   June 2021
7. BUTLER-LAPORTE G, Nakanishi T, Mooser V, Morrison DR, et al
   Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study.
   PLoS Med. 2021;18:e1003605.
   PubMed     Abstract available
   
   
   
8. INZAULE SC, Ondoa P, Loembe MM, Tebeje YK, et al
   COVID-19 and indirect health implications in Africa: Impact, mitigation measures, and lessons learned for improved disease control.
   PLoS Med. 2021;18:e1003666.
   PubMed     Abstract available
   
   
   
9. MAO W, Ogbuoji O, Watkins D, Bharali I, et al
   Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19.
   PLoS Med. 2021;18:e1003675.
   PubMed     Abstract available
   
   
   May 2021
10. GOLDMAN M, Hermans C
    Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunity.
    PLoS Med. 2021;18:e1003648.
    PubMed     Abstract available
    
    
    
11. STOKES AC, Lundberg DJ, Elo IT, Hempstead K, et al
    COVID-19 and excess mortality in the United States: A county-level analysis.
    PLoS Med. 2021;18:e1003571.
    PubMed     Abstract available
    
    
    April 2021
12. KRISHNAN A, Dar L, Saha S, Narayan VV, et al
    Efficacy of live attenuated and inactivated influenza vaccines among children in rural India: A 2-year, randomized, triple-blind, placebo-controlled trial.
    PLoS Med. 2021;18:e1003609.
    PubMed     Abstract available
    
    
    
13. ABIMBOLA S, Asthana S, Montenegro C, Guinto RR, et al
    Addressing power asymmetries in global health: Imperatives in the wake of the COVID-19 pandemic.
    PLoS Med. 2021;18:e1003604.
    PubMed     Abstract available
    
    
    
14. GRANTZ KH, Lee EC, D'Agostino McGowan L, Lee KH, et al
    Maximizing and evaluating the impact of test-trace-isolate programs: A modeling study.
    PLoS Med. 2021;18:e1003585.
    PubMed     Abstract available
    
    
    March 2021
15. LAFOND KE, Porter RM, Whaley MJ, Suizan Z, et al
    Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: A systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003550.
    PubMed     Abstract available
    
    
    
16. BALCELLS ME, Rojas L, Le Corre N, Martinez-Valdebenito C, et al
    Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial.
    PLoS Med. 2021;18:e1003415.
    PubMed     Abstract available
    
    
    
17. REID M, Abdool-Karim Q, Geng E, Goosby E, et al
    How will COVID-19 transform global health post-pandemic? Defining research and investment opportunities and priorities.
    PLoS Med. 2021;18:e1003564.
    PubMed     Abstract available
    
    
    
18. LEONG A, Cole JB, Brenner LN, Meigs JB, et al
    Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis.
    PLoS Med. 2021;18:e1003553.
    PubMed     Abstract available
    
    
    January 2021
19. SELIGMAN B, Ferranna M, Bloom DE
    Social determinants of mortality from COVID-19: A simulation study using NHANES.
    PLoS Med. 2021;18:e1003490.
    PubMed     Abstract available
    
    
    December 2020
20. KIM MS, An MH, Kim WJ, Hwang TH, et al
    Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis.
    PLoS Med. 2020;17:e1003501.
    PubMed     Abstract available
    
    
    October 2020
21. MAKARONIDIS J, Mok J, Balogun N, Magee CG, et al
    Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study.
    PLoS Med. 2020;17:e1003358.
    PubMed     Abstract available
    
    
    
22. MCKEIGUE PM, Weir A, Bishop J, McGurnaghan SJ, et al
    Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study.
    PLoS Med. 2020;17:e1003374.
    PubMed     Abstract available
    
    
    
23. BASSETT MT, Chen JT, Krieger N
    Variation in racial/ethnic disparities in COVID-19 mortality by age in the United States: A cross-sectional study.
    PLoS Med. 2020;17:e1003402.
    PubMed     Abstract available
    
    
    
24. KOLHE NV, Fluck RJ, Selby NM, Taal MW, et al
    Acute kidney injury associated with COVID-19: A retrospective cohort study.
    PLoS Med. 2020;17:e1003406.
    PubMed     Abstract available
    
    
    September 2020
25. LUND LC, Kristensen KB, Reilev M, Christensen S, et al
    Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study.
    PLoS Med. 2020;17:e1003308.
    PubMed     Abstract available
    
    
    
26. WHITE NJ, Watson JA, Hoglund RM, Chan XHS, et al
    COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.
    PLoS Med. 2020;17:e1003252.
    PubMed     Abstract available
    
    
    
27. HARRISON SL, Fazio-Eynullayeva E, Lane DA, Underhill P, et al
    Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis.
    PLoS Med. 2020;17:e1003321.
    PubMed     Abstract available
    
    
    
28. BUITRAGO-GARCIA D, Egli-Gany D, Counotte MJ, Hossmann S, et al
    Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis.
    PLoS Med. 2020;17:e1003346.
    PubMed     Abstract available
    
    
    
29. RENTSCH CT, Kidwai-Khan F, Tate JP, Park LS, et al
    Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study.
    PLoS Med. 2020;17:e1003379.
    PubMed     Abstract available
    
    
    
30. JUUL S, Nielsen EE, Feinberg J, Siddiqui F, et al
    Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).
    PLoS Med. 2020;17:e1003293.
    PubMed     Abstract available
    
    
    
31. STOWE J, Andrews N, Gringras P, Quinnell T, et al
    Reassessment of the risk of narcolepsy in children in England 8 years after receipt of the AS03-adjuvanted H1N1 pandemic vaccine: A case-coverage study.
    PLoS Med. 2020;17:e1003225.
    PubMed     Abstract available
    
    
    August 2020
32. BENJAMIN-CHUNG J, Arnold BF, Kennedy CJ, Mishra K, et al
    Evaluation of a city-wide school-located influenza vaccination program in Oakland, California, with respect to vaccination coverage, school absences, and laboratory-confirmed influenza: A matched cohort study.
    PLoS Med. 2020;17:e1003238.
    PubMed     Abstract available
    
    
    
33. SIEDNER MJ, Harling G, Reynolds Z, Gilbert RF, et al
    Social distancing to slow the US COVID-19 epidemic: Longitudinal pretest-posttest comparison group study.
    PLoS Med. 2020;17:e1003244.
    PubMed     Abstract available
    
    
    
34. HARRINGTON DM, O'Reilly M
    The reimagination of school-based physical activity research in the COVID-19 era.
    PLoS Med. 2020;17:e1003267.
    PubMed     Abstract available
    
    
    July 2020
35. SAVICKAS V, Stewart AJ, Rees-Roberts M, Short V, et al
    Opportunistic screening for atrial fibrillation by clinical pharmacists in UK general practice during the influenza vaccination season: A cross-sectional feasibility study.
    PLoS Med. 2020;17:e1003197.
    PubMed     Abstract available
    
    
    
36. TESLYA A, Pham TM, Godijk NG, Kretzschmar ME, et al
    Impact of self-imposed prevention measures and short-term government-imposed social distancing on mitigating and delaying a COVID-19 epidemic: A modelling study.
    PLoS Med. 2020;17:e1003166.
    PubMed     Abstract available
    
    
    
37. PINOTTI F, Di Domenico L, Ortega E, Mancastroppa M, et al
    Tracing and analysis of 288 early SARS-CoV-2 infections outside China: A modeling study.
    PLoS Med. 2020;17:e1003193.
    PubMed     Abstract available
    
    
    
38. WU YT, Liu J, Xu JJ, Chen YF, et al
    Neonatal outcome in 29 pregnant women with COVID-19: A retrospective study in Wuhan, China.
    PLoS Med. 2020;17:e1003195.
    PubMed     Abstract available
    
    
    
39. HAUSER A, Counotte MJ, Margossian CC, Konstantinoudis G, et al
    Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe.
    PLoS Med. 2020;17:e1003189.
    PubMed     Abstract available
    
    
    
40. ZHANG L, Tao Y, Shen M, Fairley CK, et al
    Can self-imposed prevention measures mitigate the COVID-19 epidemic?
    PLoS Med. 2020;17:e1003240.
    PubMed     Abstract available
    
    
    
41. ADAMS J
    Addressing socioeconomic inequalities in obesity: Democratising access to resources for achieving and maintaining a healthy weight.
    PLoS Med. 2020;17:e1003243.
    PubMed    
    
    
    June 2020
42. TRUELOVE S, Abrahim O, Altare C, Lauer SA, et al
    The potential impact of COVID-19 in refugee camps in Bangladesh and beyond: A modeling study.
    PLoS Med. 2020;17:e1003144.
    PubMed     Abstract available
    
    
    
43. ZHANG C, Gu J, Chen Q, Deng N, et al
    Clinical and epidemiological characteristics of pediatric SARS-CoV-2 infections in China: A multicenter case series.
    PLoS Med. 2020;17:e1003130.
    PubMed     Abstract available
    
    
    
44. GREENHALGH T
    Will COVID-19 be evidence-based medicine's nemesis?
    PLoS Med. 2020;17:e1003266.
    PubMed    
    
    
    May 2020
45. KAZATCHKINE MD, Goldman M, Vincent JL
    Antibody-based therapies for COVID-19: Can Europe move faster?
    PLoS Med. 2020;17:e1003127.
    PubMed     Abstract available
    
    
    
46. 
    Pandemic preparedness and responses: WHO to turn to in a crisis?
    PLoS Med. 2020;17:e1003167.
    PubMed     Abstract available
    
    
    April 2020
47. 
    Pandemic responses: Planning to neutralize SARS-CoV-2 and prepare for future outbreaks.
    PLoS Med. 2020;17:e1003123.
    PubMed     Abstract available
    
    
    March 2020
48. FORSTER AH, Witham K, Depelsenaire ACI, Veitch M, et al
    Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial.
    PLoS Med. 2020;17:e1003024.
    PubMed     Abstract available
    
    
    January 2020
49. SHEARER FM, Moss R, McVernon J, Ross JV, et al
    Infectious disease pandemic planning and response: Incorporating decision analysis.
    PLoS Med. 2020;17:e1003018.
    PubMed     Abstract available
    
    
    June 2019
50. CHIAVENNA C, Presanis AM, Charlett A, de Lusignan S, et al
    Estimating age-stratified influenza-associated invasive pneumococcal disease in England: A time-series model based on population surveillance data.
    PLoS Med. 2019;16:e1002829.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: